Lexaria Bioscience (LEXX) FCF Margin Growth (1y) (2018 - 2026)

Lexaria Bioscience (LEXX) FCF Margin Growth (1y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 5,389.00
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 1,525.00
9 Abivax 94.37 Bn 94.37 Bn - -
10 Lexaria Bioscience 7.17 Mn 1.65 Mn 20,000.00 -1.02 Mn

Historic Data

Download Data
DateValue
Feb 28, 2026 -1.02 Mn
Aug 31, 2025 78,450.00
May 31, 2025 -55,251.00
Feb 28, 2025 -43,354.00
Nov 30, 2024 -71,445.00
Aug 31, 2024 297,212.00
May 31, 2024 79,110.00
Feb 29, 2024 577,256.00
Nov 30, 2023 51,403.00
Aug 31, 2023 -445,707.00
May 31, 2023 -102,880.00
Feb 28, 2023 -203,260.00
Nov 30, 2022 741,306.00
Aug 31, 2022 -80,060.00
May 31, 2022 -70,268.00
Feb 28, 2022 -383,506.00
Nov 30, 2021 -843,440.00
Aug 31, 2021 98,152.00
May 31, 2021 127,394.00
Feb 28, 2021 167,552.00